# FDA Inspection 1106604 - Annora Pharma Private Limited - September 13, 2019

Source: https://www.keypedia.com/records/fda_inspections/annora-pharma-private-limited/e7f3c8a8-662c-41e7-abfb-6061f4528d17
Source feed: FDA_Inspections

> FDA Inspection 1106604 for Annora Pharma Private Limited on September 13, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1106604
- Company Name: Annora Pharma Private Limited
- Inspection Date: 2019-09-13
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1265765 - 2025-03-28](https://www.keypedia.com/records/fda_inspections/annora-pharma-private-limited/4f87f8c2-8cf8-456f-b168-622329aa8474)
- [FDA Inspection 1265765 - 2025-03-28](https://www.keypedia.com/records/fda_inspections/annora-pharma-private-limited/9dec5a07-ecf9-4d68-8e73-970888a7d027)
- [FDA Inspection 1269231 - 2025-03-13](https://www.keypedia.com/records/fda_inspections/annora-pharma-private-limited/baa3a032-b188-4db8-8f98-f68d7a00f0f6)
- [FDA Inspection 1269231 - 2025-03-13](https://www.keypedia.com/records/fda_inspections/annora-pharma-private-limited/01b91071-cb9b-4268-891e-8680591f6377)
- [FDA Inspection 1075279 - 2018-11-10](https://www.keypedia.com/records/fda_inspections/annora-pharma-private-limited/380f0ff0-075f-4591-9e86-5e7d1f1eea83)

Company: https://www.keypedia.com/companies/annora-pharma-private-limited/56c2660f-0cb1-43e2-9795-7d53f21a6cb3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c